Podcast: Regulus Therapeutics and Outsourcing Strategies - - BioPharm International

ADVERTISEMENT

Podcast: Regulus Therapeutics and Outsourcing Strategies


blog comments powered by Disqus


Focusing on outsourcing strategies, BioPharm International interviews for a second time Bal Bhat, senior director and head of chemistry at Regulus, a company that develops and manufactures oligonucleotides to support the discovery and development of microRNA therapeutics. Bhat discusses the reasoning behind Regulus’ choice of outsourcing partners and how working closely with those partners to harmonize methodology and data quality is crucial. Bhat also describes how engaging outsourcing partners with the excitement of microRNA technology enabled an improved working relationship with shared goals. Posted Nov. 2011.

Related article on Perspectives in MicroRNA Therapeutics

Podcast: Dr. Bhat focuses on microRNA Drug Delivery

ADVERTISEMENT

ADVERTISEMENT

Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
USP Center in Ghana Receives International Lab Accreditation
August 15, 2014
USP Awards Analytical Research
August 15, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
Author Guidelines

Click here